VAJRO, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 27.183
AS - Asia 15.131
EU - Europa 6.426
SA - Sud America 1.045
AF - Africa 177
Continente sconosciuto - Info sul continente non disponibili 49
OC - Oceania 16
Totale 50.027
Nazione #
US - Stati Uniti d'America 26.947
HK - Hong Kong 6.532
SG - Singapore 3.760
CN - Cina 2.093
UA - Ucraina 1.696
IT - Italia 1.415
VN - Vietnam 1.018
BR - Brasile 795
DE - Germania 749
RU - Federazione Russa 578
IE - Irlanda 529
FR - Francia 452
IL - Israele 369
FI - Finlandia 368
KR - Corea 360
TR - Turchia 325
SE - Svezia 227
IN - India 186
CA - Canada 143
GB - Regno Unito 131
AR - Argentina 104
BD - Bangladesh 76
MX - Messico 69
IQ - Iraq 60
JP - Giappone 60
PL - Polonia 57
ZA - Sudafrica 48
EU - Europa 47
PK - Pakistan 46
AT - Austria 45
ES - Italia 45
ID - Indonesia 43
EC - Ecuador 38
NL - Olanda 38
VE - Venezuela 36
UZ - Uzbekistan 26
SA - Arabia Saudita 24
TN - Tunisia 24
CO - Colombia 22
MY - Malesia 22
PH - Filippine 20
EG - Egitto 19
MA - Marocco 16
CL - Cile 15
ET - Etiopia 15
AE - Emirati Arabi Uniti 14
CZ - Repubblica Ceca 14
DZ - Algeria 14
KE - Kenya 14
PY - Paraguay 14
AU - Australia 12
IR - Iran 11
JO - Giordania 11
LT - Lituania 11
NP - Nepal 10
AL - Albania 9
AZ - Azerbaigian 9
RO - Romania 9
OM - Oman 8
PE - Perù 8
BY - Bielorussia 7
GR - Grecia 7
UY - Uruguay 7
KZ - Kazakistan 6
LB - Libano 6
BO - Bolivia 5
DK - Danimarca 5
CH - Svizzera 4
KG - Kirghizistan 4
KW - Kuwait 4
LU - Lussemburgo 4
NZ - Nuova Zelanda 4
PA - Panama 4
PT - Portogallo 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
CR - Costa Rica 3
HN - Honduras 3
HU - Ungheria 3
JM - Giamaica 3
MN - Mongolia 3
PS - Palestinian Territory 3
QA - Qatar 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AF - Afghanistan, Repubblica islamica di 2
BE - Belgio 2
BN - Brunei Darussalam 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GE - Georgia 2
HR - Croazia 2
MD - Moldavia 2
MR - Mauritania 2
NG - Nigeria 2
SV - El Salvador 2
TW - Taiwan 2
UG - Uganda 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 49.991
Città #
Hong Kong 6.511
Ann Arbor 5.988
Woodbridge 2.960
Wilmington 2.672
Singapore 2.066
Jacksonville 2.047
Houston 1.690
Chandler 1.531
San Jose 1.514
Princeton 1.425
Dallas 925
Ashburn 887
Dublin 521
Council Bluffs 450
Dong Ket 407
Lauterbourg 372
Nanjing 364
The Dalles 359
Andover 354
Dearborn 349
Beijing 309
Boardman 305
Pellezzano 286
Izmir 277
Mestre 277
Düsseldorf 223
Ho Chi Minh City 197
Moscow 158
Hanoi 155
Salerno 142
Fairfield 129
Los Angeles 126
Shenyang 124
Nanchang 119
Changsha 116
Hebei 114
Jiaxing 102
New York 99
São Paulo 90
Tianjin 86
Norwalk 79
Naples 74
Ottawa 64
Santa Clara 64
Tokyo 57
Brooklyn 51
Jinan 49
Warsaw 49
Orem 47
Seattle 43
Frankfurt am Main 42
Munich 39
Atlanta 38
Johannesburg 37
Washington 37
San Diego 36
Chennai 35
Stockholm 35
Chicago 32
Guangzhou 32
San Francisco 31
Montreal 30
Cambridge 29
London 29
Manchester 28
Vienna 28
Boston 27
Denver 27
Mexico City 27
Nuremberg 27
Redwood City 27
Rio de Janeiro 27
Haiphong 26
Pune 26
Columbus 25
Phoenix 25
Belo Horizonte 24
Da Nang 24
Milan 24
Helsinki 23
Baghdad 22
Tashkent 22
Amsterdam 21
Rome 20
Hangzhou 18
Venezia 18
Charlotte 17
Falls Church 17
Jakarta 17
Seoul 17
Ankara 16
Dormagen 16
Hefei 16
Napoli 16
Shanghai 16
Springfield 16
Guayaquil 15
Kunming 15
Mumbai 15
Tappahannock 15
Totale 38.645
Nome #
Clinical features and genotype-phenotype correlations in children withprogressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations. 798
Hepatitis B virus and the paediatric liver: waiting for news on the horizon 741
Efficacy of a multi-compartmental obesity prevention program (the 3P Project) in South Italy preschoolers 595
Migrazione sanitaria pediatrica: analisi epidemiologica, statistica, sociale ed economica del fenomeno in Campania 538
Characterization and burden of Campania children health migration across Italian regions during years 2006–2010: chance and/or necessity? 485
Autoimmune liver disease associated with celiac disease in childhood: a multicenter study 478
Brain abscess due to Klebsiella Pneumoniae in liver-transplanted children 395
Pediatric liver diseases and ocular changes: What hepatologists and ophthalmologists should know and share with each other 361
Celiac Disease-Associated Autoimmune Hepatitis In Childhood: Long Term Response To Treatment 340
Multiple gut-liver axis abnormalities in children with obesity with and without hepatic involvement 338
Recombinant interferon-alfa therapy in children with chronic hepatitis C 320
Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment. 302
Thyroid dysfunction and its role as a risk factor for non-alcoholic fatty liver disease: What's new 254
Evaluation of hyaluronic acid (HA) and laminin (LAM) serum levels as quantitative markers of histomorphometry-proven liver fibrosis in children with chronic B hepatitis. 243
A systematic review of pediatrics NAFLD therapy: year 2012 236
Metabolomic salivary signature of pediatric obesity related liver disease and metabolic syndrome 230
Guidelines for the screening and follow-up of infants born to anti-HCV positive mothers. 217
Maternal microbiota, prepregnancy weight, and mode of delivery: Intergenerational transmission of risk for childhood overweight and obesity 209
Prevalence and long term follow up of macroaspartate aminotransferase (macroAST) in children. 207
Self-concept and psychopatological risk in liver transplantated children. 200
Fas apo1 mutations and defective Fas-mediated apoptosis in a child with type 2a autoimmune hepatitis 199
Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. 199
Probiotics Reduce the Inflammatory Response Induced by a High-Fat Diet in theLiver of Young Rats 196
Alterations of the autoimmune regulator transcription factor and failure of central tolerance: APECED as a model. 196
Ipertransaminasemia cronica idiopatica 195
Humanization interventions in general pediatric wards: a systematic review 192
Twenty-four novel mutations in Wilson disease patients of predominantly Italian origin 191
"Classic" and "new" prothrombotic risk factors in children with portal vein thrombosis. 189
Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations. 186
Deficit staturo-ponderale nel bambino: non sempre un problema esclusivamente endocrinologico. 184
Management of adults with paediatric-onset chronic liver disease: Strategic issues for transition care 183
Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review 181
Low rate sustained response to IFN therapy in children with chronic hepatitis C (CHC) 181
A 360-Degree Overview Of Paediatric Nafld: Recent Insights 181
Genotype-phenotype correlation in Italian children with Wilson Disease 179
A NEW POSSIBLE THERAPEUTIC STRATEGY IN OBESITYRELATED LIVER DISEASE: PRELIMINARY DATA WITH LACTOBACILLUS RHAMNOSUS STRAIN GG 178
Jagged-1 mutation analysis in Italian Alagille syndrome patients. 178
Hepatic Presentation of Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): Case Report and Systematic Review 172
Diagnosis of hepatopulmonary sindrome (HPS) in children with chronic liver disease (CLD) 171
MITOCHONDRIAL DYSFUNCTION AND AUTOIMMUNITY PHENOMENA IN SHWACHMAN-DIAMOND SYNDROME RELATED LIVER DISEASE. 170
The canine copper toxicosis gene MURR1 is not implicated in thepathogenesis of Wilson disease. 170
Atypical celiac disease presenting as obesity-related liver dysfunction. 165
A practical approach to the child with abnormal liver tests. 164
Pediatric Celiac Disease, Cryptogenic Hypertransaminasemia, and Autoimmune Hepatitis. 163
Brain abscess due to Klebsiella pneumoniae in a liver-transplanted child 162
An epidemiological survey of hepatitis C virus infection in Italian children in the decade 1990-1999 162
Italian experience of pediatric liver transplantation 161
LONG-TERM ZINC THERAPY IN WILSON DISEASE CHILDREN WITH MILD LIVER DISEASE 157
Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation. 157
Autoimmune manifestations in pediatric liver transplantation recipients 154
Antioxidant vitamin E for the treatment of obesità related liver dysfunction in children with poor compliance to hypocaloric diets 154
Autoimmune liver disorders and coeliac disease in children: the SIGEP CALD study 152
A comparison of toddlers milk: are all the same? 152
Aagenaes's syndrome in an Italian child. 151
Autoimmune liver disorders and celiac dsease in children: the SIGEP CALD study 151
Textbook of liver transplatation. Transition to Adult Care: Adolescents Care 150
Systematic review and meta-analysis of the association celia disease-liver disease in the pediatric age 149
Celiac disease-related hepatic injury: Insights into associated conditions and underlying pathomechanisms 149
Congenital hepatic shunts: a pediatric series. 148
Ophthalmological findings of phenylketonuria: a survey of 14 cases. 148
Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions 147
Alagille syndrome: An overview. 146
Autoantibodies against CYP-2C19: A Novel Serum Marker in Pediatric De Novo Autoimmune Hepatitis? 146
Diagnosis of nonalcoholic fatty liver disease inchildren and adolescents: position paper of the ESPGHAN Hepatology Committee 145
A case of galactosemia misdiagnosed as cow's milk intolerance 145
IFN in pedaitric chronic hepatitis B (CHB). 144
Multiple phenotypes in phosphoglucomutase 1 deficiency. 144
‘3P (Preschool Prevention Program)’: Preliminary Results Of A Pilot Project For Early Obesity Prevention And Mediterranean Diet Promotion 143
Early detection of post-transplant lymphoproliferative disorders (PTLD) and modulation of immune suppression (IS) in liver transplant recipients by means of EBNA 1 and BZLF1 expression monitoring 143
Indications and Limitations of Bariatric Intervention in Severely Obese Children and Adolescents With and Without Non-alcoholic Steatohepatitis: the ESPGHAN Hepatology Committee Position Statement 142
Noninvasive investigation of hepatopulmonary syndrome in children and adolescents with chronic cholestasis. 142
Health-related quality of life in pediatric liver transplanted patients compared with a chronic liver disease group. 142
Nutritional problems in children with neuromotor disabilities: an Italian case series. 142
Zinc monotherapy is effective in Wilson's disease patients with mild liver disease diagnosed in childhood: a retrospective study. 141
ASYMPTOMATIC HYPERTRANSAMINASEMIA: A STILL POORLY RECOGNIZED MARKER OF EARLY DUCHENNE/BECKER MUSCULAR DYSTROPHY 140
POST-TRANSPLANT ERYTHROCYTOSIS IN PEDIATRIC LIVER RECIPIENTS: GENETIC ABNORMALITIES OF OXIGEN SENSING PATHWAY, ERYTHROPOIETIN AND JAK2 ARE NOT INVOLVED IN ITS PATHOGENESIS 140
YEAR 2010: SYSTEMATIC REVIEW OF TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN CHILDREN AND ADOLESCENTS 140
Long-term response to IFN therapy in children with chronic hepatitis C. 140
Probiotics in the treatment of Non Alcoholic Fatty Liver Disease: Further evidence in obese children 140
Orocoecal transit time in healthy and constipated children. 139
Infection with the delta agent in children 138
Mutations of ABCB4 gene in children with progressive familial intrahepatic cholestasis: a multicenter Italian study. 137
COACH syndrome: report of two brothers with congenital hepatic fibrosis, cerebellar vermis hypoplasia, oligophrenia, ataxia, and mental retardation. 137
Analisi gascromatografica dell'ossido di carbonio nell'aria espirata: possibile applicazione nel controllo del livello di esposizione al CO. 137
Pediatric non-alcoholic fatty liver disease: Recent advances. 137
Serum Transaminases in Children with Wilson's Disease. 136
Breast feeding enhances the clearance of HBsAg in infants with hepatitis B virus infection. 136
Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis. 135
Update on early cardiovascular and metabolic risk factors in children and adolescents affected with growth hormone deficiency. 135
Autoimmune manifestations in children transplanted for non-autoimmune liver diseases 135
LACTOBACILLUS RHAMNOSUS STRAIN GG DESERVES CONSIDERATION AS A THERAPEUTIC TOOL IN OBESITY-RELATED LIVER DISEASE 135
Approach to the asymptomatic child with protracted hypertransaminasemia 134
Volume and emptying of the gallbladder in patients with cystic fibrosis 134
Epidemiological profile of 806 Italian children with hepatitis C virus infection over a 15-year period 134
Lymph node fine needle cytology in the diagnosis of infectious diseases and instrumental guides: ultrasound and computed tomography 134
Hypertransaminasemia and coeliac disease 133
Posttransfusion and community-acquired hepatitis C in childhood. 133
Metabolic, hormonal, oxidative, and inflammatory factors in pediatricobesity-related liver disease 133
Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease 133
Analgesic effects of breast- and formula feeding during routine childhood immunizations up to 1 year of age 133
Totale 19.857
Categoria #
all - tutte 140.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.286


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021869 0 0 0 0 0 0 0 0 0 17 385 467
2021/20222.431 17 3 6 27 64 31 22 104 394 334 319 1.110
2022/20233.881 430 136 82 409 621 859 5 366 698 20 171 84
2023/20241.553 143 306 99 76 96 163 66 84 19 80 81 340
2024/20253.441 184 86 112 140 118 547 472 403 423 191 370 395
2025/202616.785 1.031 3.749 3.657 544 1.568 797 2.913 517 743 1.266 0 0
Totale 50.634